Value £1,182,546

Evaro

VC Funding

Seed

Healthcare & Biotech Published 31 January 2024

Summary

In a significant market movement during January 2024, Evaro was the subject of a vc funding. The transaction achieved a gross valuation of £1,182,546. Leading the round was Syndicate Room, Exceptional Ventures, the University of East Anglia, Cornerstone VC.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

Syndicate Room

Lead Investor / Acquirer

Exceptional Ventures

Lead Investor / Acquirer

the University of East Anglia

Lead Investor / Acquirer

Cornerstone VC

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Seed prioritised

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

Tortus

£3,329,083

Feb 2024

VC Funding

Reactec

£725,784

Oct 2020

VC Funding

Luna Pet Healthcare

£700,000

May 2026

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.